Different types of cancer show a germline BRCA1/2 mutation (mainly ovaries, breasts, prostate, and pancreas), and a consequent high sensitivity to DNA-damaging drugs such as platinum, doxorubicin, and topoisomerase inhibitors [6]. This evidence concerns the gene BRCA1 and cancer.